Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Barclays Maintains Equal-Weight on DexCom, Raises Price Target to $110

Barclays Maintains Equal-Weight on DexCom, Raises Price Target to $110

Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and raises the price target from $103 to $110.

byBenzinga Newsdesk

February 13, 2023

1 minute read

Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and raises the price target from $103 to $110.

What’s Going On With Alibaba Stock Monday?

By Anusuya Lahiri

October 16, 7:32 AM

Alibaba Group Holding Limited (NYSE: BABA) stock is trading lower Monday at par with the broader index KraneShares CSI China Internet ETF (NYSE: KWEB) amid reports of

BABA

News

CDC Says No Evidence Of An Increased Risk For Myocarditis Following MRNA Covid-19 Vaccination In Children Aged 6 Months–5 Years

By Benzinga Newsdesk

September 1, 11:45 AM

- Reuters

MRNA

Analyst Ratings

What 17 Analyst Ratings Have To Say About Roblox

By Benzinga Insights

March 10, 12:01 PM

Analysts have provided the following ratings for Roblox (NYSE:RBLX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

RBLX

China Sees Downfall In Automobile Sales: Reuters

By Shivani Kumaresan

July 11, 8:40 AM

China’s automobile industry association has downgraded its sales forecast for 2022, affected by a drop in commercial vehicle…

GELYF

Barclays Maintains Equal-Weight on DexCom, Raises Price Target to $110

Related Posts

What’s Going On With Alibaba Stock Monday?

CDC Says No Evidence Of An Increased Risk For Myocarditis Following MRNA Covid-19 Vaccination In Children Aged 6 Months–5 Years

What 17 Analyst Ratings Have To Say About Roblox

China Sees Downfall In Automobile Sales: Reuters